| Year |
Title |
Altmetric |
| 2019
|
The Virtual Short Physical Performance Battery: Psychometric Properties and Validation in Older Adults With Multiple Sclerosis
2019
|
|
| 2019
|
Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing.
2019
|
|
| 2019
|
Drug–drug interactions with cannabidiol (CBD) appear to have no effect on treatment response in an open-label Expanded Access Program
2019
|
|
| 2019
|
Early complement genes are associated with visual system degeneration in multiple sclerosis
2019
|
|
| 2019
|
Video telehealth pulmonary rehabilitation intervention in chronic obstructive pulmonary disease reduces 30-day readmissions
2019
|
|
| 2019
|
Cognitive functioning following long-term cannabidiol use in adults with treatment-resistant epilepsy
2019
|
|
| 2019
|
Higher satisfaction and adherence with glatiramer acetate 40 mg/mL TIW vs 20 mg/mL QD in RRMS
2019
|
|
| 2019
|
Examining the impact of refractory myasthenia gravis on healthcare resource utilization in the United States: Analysis of a myasthenia gravis foundation of america patient registry sample
2019
|
|
| 2019
|
Tuberous Sclerosis Complex Genotypes and Developmental Phenotype
2019
|
|
| 2019
|
Cortical Activation Elicited by Subthalamic Deep Brain Stimulation Predicts Postoperative Motor Side Effects
2019
|
|
| 2019
|
Evaluation of a web-based fall prevention program among people with multiple sclerosis
2019
|
|
| 2019
|
Impact of Refractory Myasthenia Gravis on Health-Related Quality of Life
2019
|
|
| 2019
|
Implementation of Occupational Sun Safety at a 2-Year Follow-Up in a Randomized Trial: Comparison of Sun Safe Workplaces Policy Intervention to Attention Control
2019
|
|
| 2019
|
Multiple sclerosis: Clinical trial design 2019
2019
|
|
| 2019
|
Rationale and design of the STEP for MS Trial: Comparative effectiveness of Supervised versus Telerehabilitation Exercise Programs for Multiple Sclerosis
2019
|
|
| 2019
|
The association of fatigue and social participation in multiple sclerosis as assessed using two different instruments
2019
|
|
| 2019
|
Hand stereotypies: Lessons from the Rett Syndrome Natural History Study
2019
|
|
| 2019
|
An intervention for changing sedentary behavior among African Americans with multiple sclerosis: Protocol
2019
|
|
| 2019
|
Clinical trials in multiple sclerosis: potential future trial designs
2019
|
|
| 2019
|
Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b
2019
|
|
| 2019
|
Impacting development in infants with tuberous sclerosis complex: Multidisciplinary research collaboration
2019
|
|
| 2019
|
Validation of the SymptoMScreen with performance-based or clinician-assessed outcomes
2019
|
|
| 2019
|
A new way to estimate neurologic disease prevalence in the United States: Illustrated with MS
2019
|
|
| 2019
|
The prevalence of MS in the United States: A population-based estimate using health claims data
2019
|
|
| 2019
|
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial
2019
|
|
| 2019
|
Evolution of clinical trials in multiple sclerosis
2019
|
|
| 2019
|
Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trial
2019
|
|
| 2019
|
A Randomized Internet-Based Pilot Feasibility and Planning Study of Cherry Extract and Diet Modification in Gout.
2019
|
|
| 2019
|
CYP3A5 genotype affects time to therapeutic tacrolimus level in pediatric kidney transplant recipients
2019
|
|
| 2019
|
Developing a crosswalk between the RAND-12 and the health utilities index for multiple sclerosis
2019
|
|
| 2019
|
Increased electroencephalography connectivity precedes epileptic spasm onset in infants with tuberous sclerosis complex
2019
|
|
| 2019
|
Measures of general and abdominal obesity and disability severity in a large population of people with multiple sclerosis
2019
|
|
| 2019
|
Outcomes of Endovascular Thrombectomy vs Medical Management Alone in Patients With Large Ischemic Cores: A Secondary Analysis of the Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT) Study
2019
|
|
| 2019
|
Use of eHealth and mHealth technology by persons with multiple sclerosis
2019
|
|
| 2018
|
High vigabatrin dosage is associated with lower risk of infantile spasms relapse among children with tuberous sclerosis complex
2018
|
|
| 2018
|
Medical Rehabilitation: Guidelines to Advance the Field With High-Impact Clinical Trials
2018
|
|
| 2018
|
Pseudobulbar affect prevalence and association with symptoms inmultiple sclerosis
2018
|
|
| 2018
|
Rationale and design of a single-blind, randomised controlled trial of exercise training for managing learning and memory impairment in persons with multiple sclerosis
2018
|
|
| 2018
|
Association of Concomitant Use of Cholinesterase Inhibitors or Memantine With Cognitive Decline in Alzheimer Clinical Trials: A Meta-analysis
2018
|
|
| 2018
|
Gender differences in prednisone adverse effects Survey result from the MG registry
2018
|
|
| 2018
|
Occupational Therapy Treatment to Improve Upper Extremity Function in Individuals with Early Systemic Sclerosis: A Pilot Study
2018
|
|
| 2018
|
Divergent effects of AKI to CKD models on inflammation and fibrosis
2018
|
|
| 2018
|
Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study
2018
|
|
| 2018
|
The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability
2018
|
|
| 2018
|
An introduction to Mendelian randomization with applications in neurology
2018
|
|
| 2018
|
Phase-III, randomized controlled trial of the behavioral intervention for increasing physical activity in multiple sclerosis: Project BIPAMS
2018
|
|
| 2018
|
Gender and quality of life in myasthenia gravis patients from the myasthenia gravis foundation of America registry
2018
|
|
| 2018
|
Mortality in neuromyelitis optica is strongly associated with African ancestry
2018
|
|
| 2018
|
A contemporary profile of primary progressive multiple sclerosis participants from the NARCOMS Registry
2018
|
|
| 2018
|
Histopathology of thymectomy specimens from the MGTX-trial: Entropy analysis as strategy to quantify spatial heterogeneity of lymphoid follicle and fat distribution
2018
|
|
| 2018
|
A survey of dietary characteristics in a large population of people with multiple sclerosis
2018
|
|
| 2018
|
Results of a Randomized Trial on an Intervention Promoting Adoption of Occupational Sun Protection Policies
2018
|
|
| 2018
|
Factors associated with excessive sitting time in multiple sclerosis
2018
|
|
| 2018
|
Declining Financial Capacity in Mild Cognitive Impairment: A Six-Year Longitudinal Study
2018
|
|
| 2018
|
Defining standard enzymatic dissociation methods for individual brains and spinal cords in EAE
2018
|
|
| 2018
|
Phase II Randomized Controlled Trial of Constraint-Induced Movement Therapy in Multiple Sclerosis. Part 1: Effects on Real-World Function
2018
|
|
| 2018
|
Understanding and preventing loss to follow-up: Experiences from the spinal cord injury model systems
2018
|
|
| 2018
|
Accuracy of blood pressure measurement devices in pregnancy: A systematic review of validation studies
2018
|
|
| 2018
|
Treatment satisfaction and bothersome bladder, bowel, sexual symptoms in multiple sclerosis
2018
|
|
| 2018
|
Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study
Pongkiat Kankirawatana, Dr Rani Singh, Professor David G Standaert, Dr Yuliang Liu, Dr Leon Dure, Dr Jennifer DeWollfe, Professor Gary Cutter, Dr Tyler Gaston, Dr Ashley Thomas, Professor E. Martina Bebin, Dr. Lawrence Ver Hoef
2018
|
|
| 2018
|
Clinical trials in multiple sclerosis: milestones
2018
|
|
| 2018
|
Diet quality is associated with disability and symptom severity in multiple sclerosis
2018
|
|
| 2018
|
DuraGraft vascular conduit preservation solution in patients undergoing coronary artery bypass grafting: rationale and design of a within-patient randomised multicentre trial.
2018
|
|
| 2018
|
Learning from the past: Reflections on recently completed myasthenia gravis trials
2018
|
|
| 2018
|
National estimates of self-reported sitting time in adults with multiple sclerosis.
2018
|
|
| 2018
|
Neurofibromatosis Clinical Trial Consortium
2018
|
|
| 2018
|
Short-term disability progression in two multiethnic multiple sclerosis centers in the treatment era
2018
|
|
| 2018
|
Sun safe workplaces: Effect of an occupational skin cancer prevention program on employee sun safety practices
2018
|
|
| 2017
|
A Randomized Trial of an Advanced Sun Safety Intervention for Vacationers at 41 North American Resorts
2017
|
|
| 2017
|
Pedestrian safety in patients with Parkinson's disease: A case-control study
2017
|
|
| 2017
|
Presentation and diagnosis of tuberous sclerosis complex in infants
2017
|
|
| 2017
|
Long-term follow-up of a randomized study of combination interferon and glatiramer acetate in multiple sclerosis: Efficacy and safety results up to 7 years
2017
|
|
| 2017
|
Challenging Assumptions About African American Participation in Alzheimer Disease Trials
2017
|
|
| 2017
|
Clinical trial design for progressive MS trials
2017
|
|
| 2017
|
Utility of the Autism Observation Scale for Infants in Early Identification of Autism in Tuberous Sclerosis Complex
2017
|
|
| 2017
|
Author response: High hypothetical interest in physician-assisted death in multiple sclerosis
2017
|
|
| 2017
|
Evaluating risk factors for chronic kidney disease in pediatric patients with sickle cell anemia
2017
|
|
| 2017
|
Interactions between cannabidiol and commonly used antiepileptic drugs
2017
|
|
| 2017
|
Laquinimod has no effects on brain volume or cellular CNS composition in the F1 3xTg-AD/C3H mouse model of Alzheimer's disease
2017
|
|
| 2017
|
Erratum to: Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study (Osteoporosis International, (2017), 28, 8, (2495-2503), 10.1007/s00198-017-4073-5)
2017
|
|
| 2017
|
Perspectives on marijuana use and effectiveness: A survey of NARCOMS participants
2017
|
|
| 2017
|
Dysregulation of 14-3-3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathology
2017
|
|
| 2017
|
Which symptoms contribute the most to patients' perception of health in multiple sclerosis?
2017
|
|
| 2017
|
Baseline EDSS proportions in MS clinical trials affect the overall outcome and power: A cautionary note
2017
|
|
| 2017
|
Comparative effectiveness of delayed-release dimethyl fumarate versus glatiramer acetate in multiple sclerosis patients: Results of a matching-adjusted indirect comparison
2017
|
|
| 2017
|
Effect of an intervention on observed sun protection by vacationers in a randomized controlled trial at North American resorts
2017
|
|
| 2017
|
Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study
2017
|
|
| 2017
|
Employment and absenteeism in working-age persons with multiple sclerosis
2017
|
|
| 2017
|
Publication outcomes of abstracts from the American Society of Hematology Annual Meeting
2017
|
|
| 2017
|
The effect of unilateral subthalamic nucleus deep brain stimulation on depression in Parkinson's disease
2017
|
|
| 2017
|
High hypothetical interest in physician-assisted death in multiple sclerosis
2017
|
|
| 2017
|
Assessment of Caregiver Inventory for Rett Syndrome
2017
|
|
| 2017
|
Potentially Modifiable Factors Associated With Physical Activity in Individuals With Multiple Sclerosis
2017
|
|
| 2017
|
Upper limb impairment is associated with use of assistive devices and unemployment in multiple sclerosis
2017
|
|
| 2017
|
Natalizumab-associated PML: Challenges with incidence, resulting risk, and risk stratification
2017
|
|
| 2017
|
Prevalence of Sun Protection at Outdoor Recreation and Leisure Venues at Resorts in North America
2017
|
|
| 2017
|
Association between early childhood caries and colonization with streptococcus mutans genotypes from mothers
2017
|
|
| 2017
|
Effects of Subthalamic Nucleus Deep Brain Stimulation on Objective Sleep Outcomes in Parkinson's Disease
2017
|
|
| 2017
|
Continuous electroencephalography (cEEG) monitoring and outcomes of critically Ill patients
2017
|
|
| 2017
|
Is multiple sclerosis a length-dependent central axonopathy? The case for therapeutic lag and the asynchronous progressive MS hypotheses
2017
|
|
| 2017
|
A framework of care in multiple sclerosis, part 2: Symptomatic care and beyond
2017
|
|
| 2017
|
Comparative utility of disability progression measures in PPMS: Analysis of the PROMiSe data set
2017
|
|
| 2017
|
Neurocognitive Predictors of Declining Financial Capacity in Persons with Mild Cognitive Impairment
2017
|
|
| 2017
|
Trigeminal neuralgia commonly precedes the diagnosis of multiple sclerosis
2017
|
|
| 2016
|
Correction to: Prevalence odds ratio versus prevalence ratio: choice comes with consequences: Prevalence odds ratio versus prevalence ratio (Statistics in Medicine, (2016), 35, 30, (5730-5735), 10.1002/sim.7059)
2016
|
|
| 2016
|
Prevalence odds ratio versus prevalence ratio: choice comes with consequences
2016
|
|
| 2016
|
Clinical trials: To catch a crook, you might try statistics
2016
|
|
| 2016
|
Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1
2016
|
|
| 2016
|
International clinimetric evaluation of the MG-QOL15, resulting in slight revision and subsequent validation of the MG-QOL15r
2016
|
|
| 2016
|
Sustained High Level of Healthcare Worker Adherence with Hand Hygiene Practice Recommendations Using the Patient-as-Observer Approach in the Ambulatory Setting
2016
|
|
| 2016
|
The authors reply
2016
|
|
| 2016
|
Examining the joint effect of disability, health behaviors, and comorbidity on mortality in MS
2016
|
|
| 2016
|
Long-term evolution of multiple sclerosis disability in the treatment era
2016
|
|
| 2016
|
Adjunctive azithromycin prophylaxis for cesarean delivery
2016
|
|
| 2016
|
Laquinimod efficacy in relapsing-remitting multiple sclerosis: How to understand why and if studies disagree
2016
|
|
| 2016
|
T cell cytokine signatures: Biomarkers in pediatric multiple sclerosis
2016
|
|
| 2016
|
Randomized trial of thymectomy in myasthenia gravis
2016
|
|
| 2016
|
Health insurance affects the use of disease-modifying therapy in multiple sclerosis
2016
|
|
| 2016
|
Declines in the diagnosis of primary progressive MS: A critical change in phenotype or critical measurement error?
2016
|
|
| 2016
|
Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: An analysis from the EPOC (Evaluate Patient OutComes) trial
2016
|
|
| 2016
|
Placebo-controlled study in neuromyelitis optica - Ethical and design considerations
2016
|
|
| 2016
|
Rigorous control conditions diminish treatment effects in weight loss-randomized controlled trials
2016
|
|
| 2016
|
Analysis of diagnoses associated with multiple sclerosis-related in-hospital mortality using the premier hospital database
2016
|
|
| 2016
|
Relapse May Serve as a Mediator Variable in Longitudinal Outcomes in Multiple Sclerosis
2016
|
|
| 2016
|
Long-term registries
2016
|
|
| 2016
|
Relationship between symptom change, relapse activity and disability progression in multiple sclerosis
2016
|
|
| 2016
|
Relapses in multiple sclerosis: Relationship to disability
2016
|
|
| 2016
|
Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical Trials
2016
|
|
| 2016
|
Extended interval dosing of natalizumab in multiple sclerosis
2016
|
|
| 2016
|
A framework of care in multiple sclerosis, part 1: Updated disease classification and disease-modifying therapy use in specific circumstances
2016
|
|
| 2016
|
Clinical Electroencephalographic Biomarker for Impending Epilepsy in Asymptomatic Tuberous Sclerosis Complex Infants
2016
|
|
| 2016
|
Evaluation of baseline corrected QT interval and azithromycin prescriptions in an academic medical center
2016
|
|
| 2016
|
Pooling Morphometric Estimates: A Statistical Equivalence Approach
2016
|
|
| 2016
|
Randomized trial of thymectomy in myasthenia gravis
2016
|
|
| 2016
|
Rationale, design, samples, and baseline sun protection in a randomized trial on a skin cancer prevention intervention in resort environments
2016
|
|
| 2016
|
Statistical Considerations for an Adaptive Design for a Serious Rare Disease
2016
|
|
| 2015
|
Sustained use of an occupational sun safety program in a recreation industry: follow-up to a randomized trial on dissemination strategies
2015
|
|
| 2015
|
Capacity of patients with brain metastases to make treatment decisions
2015
|
|
| 2015
|
Comparative Effectiveness Using A Matching-Adjusted Indirect Comparison Between Delayed-Release Dimethyl Fumarate and Fingolimod for The Treatment of Relapsing-Remitting Multiple Sclerosis.
2015
|
|
| 2015
|
Two-group time-to-event continual reassessment method using likelihood estimation
2015
|
|
| 2015
|
Effect of sample size re-estimation in adaptive clinical trials for Alzheimer's disease and mild cognitive impairment
2015
|
|
| 2015
|
Using baseline cognitive severity for enriching Alzheimer's disease clinical trials: How does Mini-Mental State Examination predict rate of change?
2015
|
|
| 2015
|
Effect of in-painting on cortical thickness measurements in multiple sclerosis: A large cohort study
2015
|
|
| 2015
|
Factors associated with early childhood caries incidence among high caries-risk children
2015
|
|
| 2015
|
Factors associated with early childhood caries incidence among high caries-risk children
2015
|
|
| 2015
|
The promise of futility trials in neurological diseases
2015
|
|
| 2015
|
Differences in Alzheimer disease clinical trial outcomes based on age of the participants
2015
|
|
| 2015
|
Effect of switching from intramuscular interferon β-1a to oral fingolimod on time to relapse in patients with relapsing-remitting multiple sclerosis enrolled in a 1-year extension of TRANSFORMS
2015
|
|
| 2015
|
A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis
2015
|
|
| 2015
|
A systematic review of the incidence and prevalence of cancer in multiple sclerosis
2015
|
|
| 2015
|
A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis
2015
|
|
| 2015
|
A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview
2015
|
|
| 2015
|
A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis
2015
|
|
| 2015
|
Care partners and multiple sclerosis: Differential effect on men and women
2015
|
|
| 2015
|
Causes of death among persons with multiple sclerosis
2015
|
|
| 2015
|
Defining reliable disability outcomes in multiple sclerosis
2015
|
|
| 2015
|
Impact of multiple sclerosis relapse: The NARCOMS participant perspective
2015
|
|
| 2015
|
Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: An observational study using the US Department of Defense administrative claims database
2015
|
|
| 2015
|
Multiple sclerosis drugs: How much bang for the buck?
2015
|
|
| 2015
|
Prevalence and characteristics of tremor in the NARCOMS multiple sclerosis registry: A cross-sectional survey
2015
|
|
| 2015
|
Prevalence and incidence of early childhood caries among African-American children in Alabama
2015
|
|
| 2015
|
Prevalence of multiple sclerosis symptoms across lifespan: data from the NARCOMS Registry
2015
|
|
| 2015
|
Regional gray matter atrophy in relapsing remitting multiple sclerosis: Baseline analysis of multi-center data
2015
|
|
| 2015
|
Risk tolerance to MS therapies: Survey results from the NARCOMS registry
2015
|
|
| 2015
|
Systematic review of interventional sickle cell trials registered in ClinicalTrials.gov
2015
|
|
| 2015
|
The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: A systematic review
2015
|
|
| 2015
|
The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review
2015
|
|
| 2015
|
The sustainability of an occupational skin cancer prevention program
2015
|
|
| 2015
|
To treat or not to treat, that really is not the question
2015
|
|
| 2015
|
Translation of a Ski School Sun Safety Program to North American Ski and Snowboard Schools
2015
|
|
| 2015
|
VHA Multiple Sclerosis Surveillance Registry and its similarities to other contemporary multiple sclerosis cohorts
2015
|
|
| 2014
|
Item response theory-based measure of global disability in multiple sclerosis derived from the Performance Scales and related items
2014
|
|
| 2014
|
Cognition in patients with newly diagnosed brain metastasis: Profiles and implications
2014
|
|
| 2014
|
Does risk stratification decrease the risk of natalizumab-associated PML? Where is the evidence?
2014
|
|
| 2014
|
Causes of death among commercially insured multiple sclerosis patients in the United States
2014
|
|
| 2014
|
Defining the clinical course of multiple sclerosis: The 2013 revisions
2014
|
|
| 2014
|
Patient perspectives on switching disease-modifying therapies in the NARCOMS registry
2014
|
|
| 2014
|
Bifactor structure of clinical disability in relapsing multiple sclerosis
2014
|
|
| 2014
|
Effect of nicotine replacement therapy on quitting by young adults in a trial comparing cessation services
2014
|
|
| 2014
|
Digoxin and 30-day all-cause hospital admission in older patients with chronic diastolic heart failure
2014
|
|
| 2014
|
Health literacy association with health behaviors and health care utilization in multiple sclerosis: A cross-sectional study
2014
|
|
| 2014
|
A Full-Brain, Bootstrapped Analysis of Diffusion Tensor Imaging Robustly Differentiates Parkinson Disease from Healthy Controls
2014
|
|
| 2014
|
Clinical trials in multiple sclerosis
2014
|
|
| 2014
|
Composite end points to assess delay of disability progression by MS treatments
2014
|
|
| 2014
|
Dissemination of go sun smart in outdoor recreation: effect of program exposure on sun protection of guests at high-altitude ski areas.
2014
|
|
| 2014
|
Distinct populations of label-retaining cells in the adult kidney are defined temporally and exhibit divergent regional distributions
2014
|
|
| 2014
|
Does change in acetylcholine receptor antibody level correlate with clinical change in myasthenia gravis?
2014
|
|
| 2014
|
Does natalizumab therapy benefit patients with multiple sclerosis?
2014
|
|
| 2014
|
EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: A randomised, double-blind, placebo-controlled phase 2 clinical trial
2014
|
|
| 2014
|
Effect of APOE genotype status on targeted clinical trials outcomes and efficiency in dementia and mild cognitive impairment resulting from Alzheimer's disease
2014
|
|
| 2014
|
Effects of early inhaled nitric oxide therapy and vitamin A supplementation on the risk for bronchopulmonary dysplasia in premature newborns with respiratory failure
2014
|
|
| 2014
|
Improvement of multiple sclerosis-associated tremor as a treatment effect of natalizumab
2014
|
|
| 2014
|
Intensive care unit readmission during childhood after preterm birth with respiratory failure
2014
|
|
| 2014
|
Low invasiveness of pneumococcal serotype 11A is linked to ficolin-2 recognition of O-acetylated capsule epitopes and lectin complement pathway activation
2014
|
|
| 2014
|
Mutans streptococci enumeration and genotype selection using different bacitracin-containing media
2014
|
|
| 2014
|
Natalizumab reduces relapse clinical severity and improves relapse recovery in MS
2014
|
|
| 2014
|
No Evidence of Disease Activity: Indirect Comparisons of Oral Therapies for the Treatment of Relapsing–Remitting Multiple Sclerosis
2014
|
|
| 2014
|
Noninvasive inhaled nitric oxide does not prevent bronchopulmonary dysplasia in premature newborns
2014
|
|
| 2014
|
Pubertal development in rett syndrome deviates from typical females
2014
|
|
| 2014
|
Recruitment of participants to a multiple sclerosis trial: The CombiRx experience
2014
|
|
| 2014
|
Seabed classification using surface backscattering strength versus acoustic frequency and incidence angle measured with vertical, split-beam echosounders
2014
|
|
| 2014
|
Survival in commercially insured multiple sclerosis patients and comparator subjects in the U.S.
2014
|
|
| 2013
|
Natural history of multiple sclerosis symptoms
2013
|
|
| 2013
|
Sampling selectivity in acoustic-trawl surveys of Pacific sardine (Sardinops sagax) biomass and length distribution
2013
|
|
| 2013
|
Cost-effectiveness analyses Beauty and the beast?
2013
|
|
| 2013
|
Epidemiological features of amyotrophic lateral sclerosis in a large clinic-based African American population
2013
|
|
| 2013
|
Treatment trials in progressive MS - Current challenges and future directions
2013
|
|
| 2013
|
Mortality in patients with multiple sclerosis
2013
|
|
| 2013
|
A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis
2013
|
|
| 2013
|
MRI lesions: A surrogate for relapses in multiple sclerosis?
2013
|
|
| 2013
|
Characteristics of Streptococcus mutans genotypes and dental caries in children
2013
|
|
| 2013
|
Genomic Copy Number Variants: Evidence for Association with Antibody Response to Anthrax Vaccine Adsorbed
2013
|
|
| 2013
|
Cause of death in MS: Longterm follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study (BMJ Open (2012) 2 (e001972))
2013
|
|
| 2013
|
Constraint-induced movement therapy for the lower extremities in multiple sclerosis: Case series with 4-year follow-up
2013
|
|
| 2013
|
Preferred sources of health information in persons with multiple sclerosis: Degree of trust and information sought
2013
|
|
| 2013
|
Disability in multiple sclerosis: A reference for patients and clinicians
2013
|
|
| 2013
|
Randomized study combining interferon and glatiramer acetate in multiple sclerosis
2013
|
|
| 2013
|
Regional cortical thickness in relapsing remitting multiple sclerosis: A multi-center study
2013
|
|
| 2013
|
"Seeing" in NARCOMS: A look at vision-related quality of life in the NARCOMS registry
2013
|
|
| 2013
|
A genetic variant of the anti-apoptotic protein Akt predicts natalizumab-induced lymphocytosis and post-natalizumab multiple sclerosis reactivation
2013
|
|
| 2013
|
A retrospective review of lithium usage in veterans with multiple sclerosis
2013
|
|
| 2013
|
EDSS variability before randomization may limit treatment discovery in primary progressive MS
2013
|
|
| 2013
|
Effect of glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab
2013
|
|
| 2013
|
Effect of physical comorbidities on risk of depression in Multiple Sclerosis
2013
|
|
| 2013
|
National variation of technical factors in computed tomography of the head
2013
|
|
| 2013
|
Reply
2013
|
|
| 2013
|
Substantial burden of dizziness in multiple sclerosis
2013
|
|
| 2013
|
The Multiple Sclerosis Intimacy and Sexuality Questionnaire - Re-validation and development of a 15-item version with a large US sample
2013
|
|
| 2013
|
The magnetic resonance imaging 'rule of five': Predicting the occurrence of relapse
2013
|
|
| 2012
|
Biomarker positive and negative subjects in the ADNI cohort: Clinical characterization
2012
|
|
| 2012
|
Cause of death in MS: Long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study
2012
|
|
| 2012
|
Inflammation, Apoptosis, and Necrosis Induced by Neoadjuvant Fas Ligand Gene Therapy Improves Survival of Dogs With Spontaneous Bone Cancer.
2012
|
|
| 2012
|
Personalized medicine: The return of the house call?
2012
|
|
| 2012
|
Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United States
2012
|
|
| 2012
|
No association between conventional brain MR imaging and chronic cerebrospinal venous insufficiency in multiple sclerosis
2012
|
|
| 2012
|
Treatment with interferon beta for multiple sclerosis
2012
|
|
| 2012
|
Short latency activation of cortex by clinically effective thalamic brain stimulation for tremor
2012
|
|
| 2012
|
Long-Term Cost-Effectiveness Model of Interferon Beta-1b in the Early Treatment of Multiple Sclerosis in the United States
2012
|
|
| 2012
|
Sustainability of the Dissemination of an Occupational Sun Protection Program in a Randomized Trial
2012
|
|
| 2012
|
Increasing age at disability milestones among MS patients in the MSBase Registry
2012
|
|
| 2012
|
Enhancing industry-based dissemination of an occupational sun protection program with theory-based strategies employing personal contact
2012
|
|
| 2012
|
Evolution of MS lesions to black holes under DNA vaccine treatment
2012
|
|
| 2012
|
Adopting an evidence-based lifestyle physical activity program: Dissemination study design and methods
2012
|
|
| 2012
|
Psychometric evaluation of the myasthenia gravis composite using rasch analysis
2012
|
|
| 2012
|
Recommendations for myasthenia gravis clinical trials
2012
|
|
| 2012
|
Short latency activation of cortex during clinically effective subthalamic deep brain stimulation for Parkinson's disease
2012
|
|
| 2012
|
Survival in MS A randomized cohort study 21 years after the start of the pivotal IFNβ-1b trial
2012
|
|
| 2012
|
The CombiRx trial of combined therapy with interferon and glatiramer cetate in relapsing remitting MS: Design and baseline characteristics.
2012
|
|
| 2012
|
Cumulative impact of comorbidity on quality of life in MS
2012
|
|
| 2012
|
Expanding occupational sun safety to an outdoor recreation industry: A translational study of the Go Sun Smart program
2012
|
|
| 2012
|
Implementing clinical trials on an international platform: Challenges and perspectives
2012
|
|
| 2012
|
Response to the Letter 'Efficiency loss due to varying cluster sizes in cluster randomized trials and how to compensate for it: Comment on You et al. (2011)' by van Breukelen and Candel
2012
|
|
| 2012
|
Biomarker development for myasthenia gravis
2012
|
|
| 2012
|
Compliance with sunscreen advice in a survey of adults engaged in outdoor winter recreation at high-elevation ski areas
2012
|
|
| 2012
|
Inflammation, apoptosis, and necrosis induced by neoadjuvant fas ligand gene therapy improves survival of dogs with spontaneous bone cancer
2012
|
|
| 2012
|
Statistical cures and other fallacies
2012
|
|
| 2012
|
The CombiRx trial of combined therapy with interferon and glatiramer acetate in relapsing remitting MS: Design and baseline characteristics
2012
|
|
| 2012
|
Unilateral subthalamic nucleus deep brain stimulation improves sleep quality in Parkinson's disease
2012
|
|
| 2011
|
Evaluation of safety monitoring guidelines based on MRI lesion activity in multiple sclerosis
2011
|
|
| 2011
|
Re: Practice parameters in myasthenia gravis
2011
|
|
| 2011
|
Real-time quantitative polymerase chain reaction for enumeration of Streptococcus mutans from oral samples
2011
|
|
| 2011
|
Reply from the authors
2011
|
|
| 2011
|
To the editor
2011
|
|
| 2011
|
Inhaled nitric oxide in preterm infants: An individual-patient data meta-analysis of randomized trials
2011
|
|
| 2011
|
Comparison of weight changes following unilateral and staged bilateral STN DBS for advanced PD
2011
|
|
| 2011
|
Erratum: Estimating power with effect size versus slope differences: Both means and variance matter (Alzheimer's and Dementia (2011) 7 (247-249))
2011
|
|
| 2011
|
Molecular subtypes of osteosarcoma identified by reducing tumor heterogeneity through an interspecies comparative approach
2011
|
|
| 2011
|
Motivating public school districts to adopt sun protection policies: A randomized controlled trial
2011
|
|
| 2011
|
Association between comorbidity and clinical characteristics of MS
2011
|
|
| 2011
|
Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS
2011
|
|
| 2011
|
A tumor-related lymphoid progenitor population supports hierarchical tumor organization in canine B-cell lymphoma
2011
|
|
| 2011
|
Got milk?
2011
|
|
| 2011
|
A research model for investigating the effects of artificial food colorings on children with ADHD
2011
|
|
| 2011
|
Physical activity and self-reported cardiovascular comorbidities in persons with multiple sclerosis: Evidence from a cross-sectional analysis
2011
|
|
| 2011
|
Bayesian sample size determination under hypothesis tests
2011
|
|
| 2011
|
Practice parameters and focusing research: Plasma exchange for myasthenia gravis
2011
|
|
| 2011
|
Interferon β-1b and glatiramer acetate effects on permanent black hole evolution
2011
|
|
| 2011
|
Smokers with multiple sclerosis are more likely to report comorbid autoimmune diseases
2011
|
|
| 2011
|
Continued benefits of a technical assistance web site to local tobacco control coalitions during a state budget shortfall
2011
|
|
| 2011
|
Estimating power with effect size versus slop differences: Both means and variance matter
2011
|
|
| 2011
|
Estimating the density of Antarctic krill (Euphausia superba) from multi-beam echo-sounder observations using distance sampling methods
2011
|
|
| 2011
|
Genetic diversity of plaque mutans streptococci with rep-PCR
2011
|
|
| 2011
|
Chronic cerebrospinal vascular insufficiency is not associated with HLA DRB1*1501 status in multiple sclerosis patients
2011
|
|
| 2011
|
Relative efficiency and sample size for cluster randomized trials with variable cluster sizes
2011
|
|
| 2011
|
Risk of serious injury for young baseball pitchers: A 10-year prospective study
2011
|
|
| 2011
|
Acute kidney injury and renal replacement therapy independently predict mortality in neonatal and pediatric noncardiac patients on extracorporeal membrane oxygenation
2011
|
|
| 2011
|
Intracortical lesions by 3T magnetic resonance imaging and correlation with cognitive impairment in multiple sclerosis
2011
|
|
| 2011
|
Substantial adverse association of visual and vascular comorbidities on visual disability in multiple sclerosis
2011
|
|
| 2011
|
Supporting tobacco control: stimulating local newspaper coverage with a technical assistance website for local coalitions.
2011
|
|
| 2011
|
Trend for decreasing Multiple Sclerosis Severity Scores (MSSS) with increasing calendar year of enrollment into the New York State Multiple Sclerosis Consortium
2011
|
|
| 2010
|
Assessing changes in relapse rates in multiple sclerosis
2010
|
|
| 2010
|
Comparative analysis of therapeutic options used for myasthenia gravis
2010
|
|
| 2010
|
Gene expression profiling identifies inflammation and angiogenesis as distinguishing features of canine hemangiosarcoma
2010
|
|
| 2010
|
Disability progression in a clinical trial of relapsing-remitting multiple sclerosis eight-year follow-up
2010
|
|
| 2010
|
Environmental cues to UV radiation and personal sun protection in outdoor winter recreation
2010
|
|
| 2010
|
Composite MRI scores improve correlation with EDSS in multiple sclerosis
2010
|
|
| 2010
|
Requiring an amyloid-β1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials
2010
|
|
| 2010
|
Modeling lesion counts in multiple sclerosis when patients have been selected for baseline activity
2010
|
|
| 2010
|
Temporal characteristics of cold pain perception
2010
|
|
| 2010
|
Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis
2010
|
|
| 2010
|
Reply from the authors
2010
|
|
| 2010
|
Variability of two plaque sampling methods in quantitation of streptococcus mutans
2010
|
|
| 2010
|
Decreased accuracy in interpretation of community-based screening mammography for women with multiple clinical risk factors
2010
|
|
| 2010
|
Inhaled Nitric Oxide in preterm infants: A systematic review and individual patient data meta-analysis
2010
|
|
| 2010
|
Impact of loss of mobility on instrumental activities of daily living and socioeconomic status in patients with MS
2010
|
|
| 2010
|
A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis
2010
|
|
| 2010
|
Considerations on discontinuing natalizumab for the treatment of multiple sclerosis
2010
|
|
| 2010
|
Optimal design and analysis of phase I/II clinical trials in multiple sclerosis with gadolinium-enhanced lesions as the endpoint
2010
|
|
| 2010
|
Reproducibility of high-resolution optical coherence tomography in multiple sclerosis
2010
|
|
| 2010
|
Sample size in obesity trials: Patient perspective versus current practice
2010
|
|
| 2010
|
Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis
2010
|
|
| 2009
|
Erratum to "The MGTX experience: Challenges in planning and executing an international, multicenter clinical trial" [J. Neuroimmunol. 201-202(2008)80-84] (DOI:10.1016/j.jneuroim.2008.05.031)
2009
|
|
| 2009
|
Evidence of treatment benefit: Is seeing believing or obfuscation by statistics?
2009
|
|
| 2009
|
Weight changes associated with unilateral STN DBS and advanced PD
2009
|
|
| 2009
|
Clinical and economic effects of iNO in premature newborns with respiratory failure at 1 year
2009
|
|
| 2009
|
Epitope-specific immunotherapy of rheumatoid arthritis: Clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trial
2009
|
|
| 2009
|
Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis
2009
|
|
| 2009
|
A bayesian method of estimating kappa coefficient with application to a rheumatoid arthritis study
2009
|
|
| 2009
|
Vision related quality of life in multiple sclerosis: Correlation with new measures of low and high contrast letter acuity
2009
|
|
| 2009
|
Testing a theory-based health communication program: A replication of go sun smart in outdoor winter recreation
2009
|
|
| 2009
|
Variability of interpretive accuracy among diagnostic mammography facilities
2009
|
|
| 2009
|
Measuring up rates for adverse health behaviors in multiple sclerosis: The need for action
2009
|
|
| 2009
|
Proof of concept studies for tissue-protective agents in multiple sclerosis
2009
|
|
| 2009
|
Multibeam echosounder observations reveal interactions between Antarctic krill and air-breathing predators
2009
|
|
| 2009
|
Retinal architecture predicts pupillary reflex metrics in MS
2009
|
|
| 2009
|
Factors that influence adherence with disease-modifying therapy in MS
2009
|
|
| 2009
|
Influence of genetic background on tumor karyotypes: Evidence for breed-associated cytogenetic aberrations in canine appendicular osteosarcoma
2009
|
|
| 2009
|
Polymorphisms in the NQO1, GSTT and GSTM genes are associated with coronary heart disease and biomarkers of oxidative stress
2009
|
|
| 2009
|
The burden of mental comorbidity in multiple sclerosis: Frequent, underdiagnosed, and undertreated
2009
|
|
| 2009
|
Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: A meta-analytic approach
2009
|
|
| 2009
|
MHC-dependent desensitization of intrinsic anti-self reactivity
2009
|
|
| 2009
|
Predictors of radiologists' perceived risk of malpractice lawsuits in breast imaging
2009
|
|
| 2009
|
Inferences and power analysis concerning two negative binomial distributions with an application to MRI lesion counts data
2009
|
|
| 2009
|
Comorbidity delays diagnosis and increases disability at diagnosis in MS
2009
|
|
| 2009
|
High frequency of adverse health behaviors in multiple sclerosis
2009
|
|
| 2009
|
A cross-sectional study of bone health in multiple sclerosis
2009
|
|
| 2009
|
Editorial: Relapses in multiple sclerosis: Important or not?
2009
|
|
| 2008
|
Optical coherence tomography: A window into the mechanisms of multiple sclerosis
2008
|
|
| 2008
|
Comorbidity, socioeconomic status and multiple sclerosis
2008
|
|
| 2008
|
Construction of an efficient evaluative instrument for myasthenia gravis: The MG composite
2008
|
|
| 2008
|
Smoking status over two years in patients with multiple sclerosis
2008
|
|
| 2008
|
Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis: Reply
2008
|
|
| 2008
|
Constraint-Induced Movement therapy can improve hemiparetic progressive multiple sclerosis. Preliminary findings
2008
|
|
| 2008
|
Effects of program exposure and engagement with tailored prevention communication on sun protection by young adolescents
2008
|
|
| 2008
|
Go Sun Smart
2008
|
|
| 2008
|
Testing the long-term effects of the Go Sun Smart worksite health communication campaign: A group-randomized experimental study
2008
|
|
| 2008
|
The MGTX experience: Challenges in planning and executing an international, multicenter clinical trial
2008
|
|
| 2008
|
Bayesian interim analysis in clinical trials
2008
|
|
| 2008
|
Novel design for clinical trials in multiple sclerosis: Another excursion to Sirenum scopuli?
2008
|
|
| 2008
|
Reproducibility of optical coherence tomography in multiple sclerosis
2008
|
|
| 2008
|
Less is more, or almost as much: A 15-item quality-of-life instrument for myasthenia gravis
2008
|
|
| 2008
|
Magnetic resonance imaging as a surrogate outcome for multiple sclerosis relapses
2008
|
|
| 2008
|
Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis
2008
|
|
| 2008
|
Increasing Sun Protection in Winter Outdoor Recreation. A Theory-Based Health Communication Program
2008
|
|
| 2008
|
Mammography facility characteristics associated with interpretive accuracy of screening mammography
2008
|
|
| 2008
|
Hyperglycemia and adverse pregnancy outcomes
2008
|
|
| 2008
|
Randomized trial evaluating computer-based sun safety education for children in elementary school
2008
|
|
| 2008
|
Randomized trial on the 5 a day, the Rio Grande way website, a web-based program to improve fruit and vegetable consumption in rural communities
2008
|
|
| 2008
|
Randomized trials on consider this, a tailored, internet-delivered smoking prevention program for adolescents
2008
|
|
| 2008
|
Corticospinal tract abnormalities are associated with weakness in multiple sclerosis
2008
|
|
| 2008
|
Ethics of placebo-controlled clinical trials in multiple sclerosis: A reassessment
2008
|
|
| 2008
|
Responsiveness and predictive values in PPMS: An uncertain message
2008
|
|
| 2008
|
Rules of evidence for clinical trials: The science of finding the truth?
2008
|
|
| 2008
|
Status of the thymectomy trial for nonthymomatous myasthenia gravis patients receiving prednisone
2008
|
|
| 2007
|
Effect of emailed messages on return use of a nutrition education website and subsequent changes in dietary behavior
2007
|
|
| 2007
|
Inactivation of the p16 cyclin-dependent kinase inhibitor in high-grade canine non-Hodgkin's T-cell lymphoma
2007
|
|
| 2007
|
Validation of the NARCOMS registry: Diagnosis
2007
|
|
| 2007
|
Disparities in the management of multiple sclerosis-related bladder symptoms
2007
|
|
| 2007
|
Testing the risk compensation hypothesis for safety helmets in alpine skiing and snowboarding
2007
|
|
| 2007
|
Randomized trial on sun safety education at ski and snowboard schools in western North America
2007
|
|
| 2007
|
Influence of computer-aided detection on performance of screening mammography
2007
|
|
| 2007
|
Interferon-β for multiple sclerosis: Long-term benefits?
2007
|
|
| 2007
|
Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trial
2007
|
|
| 2007
|
Optical coherence tomography and disease subtype in multiple sclerosis
2007
|
|
| 2007
|
Persistent pain and uncomfortable sensations in persons with multiple sclerosis
2007
|
|
| 2007
|
Predictive value of p16 or Rb inactivation in a model of naturally occurring canine non-Hodgkin's lymphoma [7]
2007
|
|
| 2007
|
Relation of vision to global and regional brain MRI in multiple sclerosis
2007
|
|
| 2007
|
Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis
2007
|
|
| 2006
|
Mediation of a middle school skin cancer prevention program
2006
|
|
| 2006
|
Early Inhaled Nitric Oxide Therapy in Premature Newborns with Respiratory Failure
2006
|
|
| 2006
|
Canine hemangiosarcoma originates from hematopoietic precursors with potential for endothelial differentiation
2006
|
|
| 2006
|
Reality check: Perceived versus actual performance of community mammographers
2006
|
|
| 2006
|
Naturally occurring translational models for development of cancer gene therapy
2006
|
|
| 2006
|
Change in clinician-assessed measures of multiple sclerosis and subject-reported quality of life: Results from the IMPACT study
2006
|
|
| 2006
|
Does multiple sclerosis-associated disability differ between races?
2006
|
|
| 2006
|
Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis
2006
|
|
| 2006
|
Futility studies: Spending a little to save a lot
2006
|
|
| 2006
|
Impact of customized videotape education on quality of life in patients with chronic obstructive pulmonary disease
2006
|
|
| 2006
|
Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis [3]
2006
|
|
| 2006
|
Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: An update
2006
|
|
| 2006
|
Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis
2006
|
|
| 2006
|
Effects of the Sunny Days, Healthy Ways curriculum on students in grades 6 to 8
2006
|
|
| 2006
|
Infectious causes of multiple sclerosis
2006
|
|
| 2005
|
Estimating long-term effects of disease-modifying drug therapy in multiple sclerosis patients
2005
|
|
| 2005
|
Changes in the ascertainment of multiple sclerosis
2005
|
|
| 2005
|
MRI as a marker for disease heterogeneity in multiple sclerosis
2005
|
|
| 2005
|
Validation of the NARCOMS Registry: Fatique assessment
2005
|
|
| 2005
|
Randomized trial testing a worksite sun protection program in an outdoor recreation industry
2005
|
|
| 2005
|
Distinct B-cell and T-cell lymphoproliferative disease prevalence among dog breeds indicates heritable risk
2005
|
|
| 2005
|
Does litigation influence medical practice? The influence of community radiologists' medical malpractice perceptions and experience on screening mammography
2005
|
|
| 2005
|
Is Bayesian analysis ready for use in phase III randomized clinical trials? Beware the sound of the sirens
2005
|
|
| 2005
|
The Goldman Consensus statement on depression in multiple sclerosis
2005
|
|
| 2005
|
Validation of the NARCOMS registry: Pain assessment
2005
|
|
| 2005
|
Current realities of delivering mammography services in the community: Do challenges with staffing and scheduling exist?
2005
|
|
| 2005
|
Mammographers' perception of women's breast cancer risk
2005
|
|
| 2005
|
Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis
2005
|
|
| 2005
|
Physician predictors of mammographic accuracy
2005
|
|
| 2005
|
Assessing accuracy of mammography in the presence of verification bias and intrareader correlation
2005
|
|
| 2005
|
Association between mammography timing and measures of screening performance in the United States
2005
|
|
| 2005
|
Community-based mammography practice: Services, charges, and interpretation methods
2005
|
|
| 2005
|
Exactly which synephrine alkaloids does Citrus aurantium (bitter orange) contain?
2005
|
|
| 2005
|
Randomized effectiveness trial of a computer-assisted intervention to improve diabetes care
2005
|
|
| 2004
|
Accuracy of screening mammography interpretation by characteristics of radiologists
2004
|
|
| 2004
|
A practical randomized trial to improve diabetes care
2004
|
|
| 2004
|
Prevalence and diffusion of helmet use at ski areas in Western North America in 2001-02
2004
|
|
| 2004
|
CCR2-64I polymorphism and CCR5Δ32 deletion in patients with Alzheimer's disease
2004
|
|
| 2004
|
Clinical characteristics of progressive relapsing multiple sclerosis
2004
|
|
| 2004
|
Effect of breast augmentation on the accuracy of mammography and cancer characteristics
2004
|
|
| 2004
|
The MS Co-Operative Research (MS-CORE) group: An alternate approach to fostering multicenter studies [1]
2004
|
|
| 2004
|
The association between obesity and screening mammography accuracy
2004
|
|
| 2004
|
Radiologist uncertainty and the interpretation of screening
2004
|
|
| 2004
|
The patient's perception of a (reliable) change in the Multiple Sclerosis Functional Composite
2004
|
|
| 2004
|
Effect of Breast Augmentation on the Accuracy of Mammography and Cancer Characteristics
2004
|
|
| 2003
|
Effect of relapses on development of residual deficit in multiple sclerosis
2003
|
|
| 2003
|
Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population
2003
|
|
| 2003
|
Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite
2003
|
|
| 2003
|
Enhancing antimelanoma immune responses through apoptosis
2003
|
|
| 2003
|
Sample size estimates for determining treatment effects in high-risk patients with early relapsing-remitting multiple sclerosis
2003
|
|
| 2003
|
Optimization of technique factors for a silicon diode array full-field digital mammography system and comparison to screen-film mammography with matched average glandular dose
2003
|
|
| 2003
|
Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography
2003
|
|
| 2003
|
Factors that predict health-related quality of life in patients with relapsing-remitting multiple sclerosis
2003
|
|
| 2003
|
The prevalence and predictors of helmet use by skiers and snowboarders at ski areas in western north america in 2001
2003
|
|
| 2002
|
Eight-year follow-up study of brain atrophy in patients with MS
2002
|
|
| 2002
|
Detection of ductal carcinoma in situ in women undergoing screening mammography
2002
|
|
| 2002
|
Benefit of interferon β-1a on MSFC progression in secondary progressive MS
2002
|
|
| 2002
|
Performance of diagnostic mammography for women with signs or symptoms of breast cancer
2002
|
|
| 2002
|
Clinical comparison of full-field digital mammography and screen-film mammography for detection of breast cancer
2002
|
|
| 2002
|
Mammography screening and differences in stage of disease by race/ethnicity
2002
|
|
| 2002
|
Performance comparison of full-field digital mammography to screen-film mammography in clinical practice
2002
|
|
| 2002
|
The Multiple Sclerosis Functional Composite: A new clinical outcome measure for multiple sclerosis trials
2002
|
|
| 2001
|
Modelling new enhancing MRI lesion counts in multiple sclerosis
2001
|
|
| 2001
|
Competing demands in the office visit: What influences mammography recommendations?
2001
|
|
| 2001
|
Use of the multiple sclerosis functional composite to predict disability in relapsing MS
2001
|
|
| 2001
|
Hypothermia as a risk factor for pediatric cardiothoracic surgical site infection
2001
|
|
| 2001
|
Comparison of full-field digital mammography with screen-film mammography for cancer detection: Results of 4,945 paired examinations
2001
|
|
| 2001
|
Rates and causes of disagreement in interpretation of full-field digital mammography and film-screen mammography in a diagnostic setting
2001
|
|
| 2001
|
The effect of degree of refractive error on hydrogel contact lens-induced complications and patient self-management behaviors
2001
|
|
| 2001
|
Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial
2001
|
|
| 2000
|
Performance of screening mammography among women with and without a first-degree relative with breast cancer
2000
|
|
| 2000
|
Clinical significance of the multiple sclerosis functional composite: Relationship to patient-reported quality of life
2000
|
|
| 2000
|
Intrarater and interrater reliability of the MS functional composite outcome measure
2000
|
|
| 2000
|
Validity of self-reported colorectal cancer screening behavior
2000
|
|
| 2000
|
New low-contrast vision charts: Reliability and test characteristics in patients with multiple sclerosis
2000
|
|
| 2000
|
Relationship between brain atrophy and disability: An 8-year follow-up study of multiple sclerosis patients
2000
|
|
| 2000
|
Self-reported visual dysfunction in multiple sclerosis: Results from the 25-Item National Eye Institute Visual Function Questionnaire (VFQ-25)
2000
|
|
| 1999
|
Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: A randomised controlled trial
1999
|
|
| 1999
|
The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force.
1999
|
|
| 1999
|
Development of a multiple sclerosis functional composite as a clinical trial outcome measure
1999
|
|
| 1999
|
A study of the relationship between family history of breast cancer and knowledge of breast cancer genetic testing prerequisites
1999
|
|
| 1999
|
Practice patterns of family physicians in practice-based research networks: a report from ASPN. Ambulatory Sentinel Pratice Network.
1999
|
|
| 1999
|
Promoting cancer screening among the first-degree relatives of breast and colorectal cancer patients: The design of two randomized trials
1999
|
|
| 1998
|
The prospective relationships between smoking and weight in a young, biracial cohort: The Coronary Artery Risk Development in Young Adults study
1998
|
|
| 1998
|
The pediatric costs of strategies for minimizing the risk of early- onset group B streptococcal disease [1] (multiple letters)
1998
|
|
| 1998
|
Improvement in mammography quality control: 1987-1995
1998
|
|
| 1998
|
Pathogenetic characterization of 1-methyl-1-nitrosourea-induced mammary carcinomas in the rat
1998
|
|
| 1998
|
The cancer information service research consortium: An emerging laboratory for cancer control research
1998
|
|
| 1997
|
The pediatric costs of strategies for minimizing the risk of early- onset group B streptococcal disease
1997
|
|
| 1997
|
Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn.
1997
|
|
| 1997
|
Long-term survival of African Americans in the Coronary Artery Surgery Study (CASS)
1997
|
|
| 1997
|
A classification system to evaluate weight maintainers, gainers, and losers
1997
|
|
| 1997
|
Evaluating the value of low-vision services.
1997
|
|
| 1997
|
Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn
1997
|
|
| 1997
|
Recommendations from the national multiple sclerosis society clinical outcomes assessment task force
1997
|
|
| 1996
|
Clinical outcomes assessment in multiple sclerosis
1996
|
|
| 1996
|
Clinical outcomes assessment in multiple sclerosis: Part II
1996
|
|
| 1996
|
Impact of maternal group B streptococcal screening on pediatric management in full-term newborns
1996
|
|
| 1996
|
Methodological issues in weight cycling
1996
|
|
| 1996
|
The clinical presentation, prevalence, and risk factors of focal corneal infiltrates in soft contact lens wearers
1996
|
|
| 1995
|
Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis
1995
|
|
| 1995
|
The association of heparin exposure with intraventricular hemorrhage among very low birth weight infants.
1995
|
|
| 1995
|
Psychological correlates of weight fluctuation.
1995
|
|
| 1995
|
Optometric Care and Undetected Eye Disease: A Case of Berkson's Bias?
1995
|
|
| 1995
|
Cervical examination and tocodynamometry at 28 weeks' gestation: prediction of spontaneous preterm birth.
1995
|
|
| 1995
|
A new device for collecting cord blood
1995
|
|
| 1995
|
Cervical examination and tocodynamometry at 28 weeks' gestation: Prediction of spontaneous preterm birth
1995
|
|
| 1995
|
Clinical outcomes and documentation of partial beneficial effects of immunotherapy for multiple sclerosis
1995
|
|
| 1995
|
Differences in the detection and enumeration of mutans streptococci due to differences in methods
1995
|
|
| 1995
|
Fetal growth in women using low-dose aspirin for the prevention of preeclampsia: Effect of maternal size
1995
|
|
| 1995
|
Impact of patient history on residents' evaluation of child sexual abuse
1995
|
|
| 1995
|
Low-dose aspirin: Lack of association with an increase in abruptio placentae or perinatal mortality
1995
|
|
| 1995
|
Maternal serum thromboxane B2 reduction versus pregnancy outcome in a low-dose aspirin trial
1995
|
|
| 1995
|
Psychological correlates of weight fluctuation
1995
|
|
| 1995
|
The Effect of Cigarette Smoking on Neonatal Anthropometric Measurements
1995
|
|
| 1995
|
The relationship between maternal and neonatal anthropometric measurements in term newborns
1995
|
|
| 1995
|
The self-management behaviors of soft contact lens wearers: The effect of lens modality
1995
|
|
| 1995
|
Who Are the Weight Maintainors?
1995
|
|
| 1994
|
A study of the reliability and comparative validity of the cardia dietary history.
1994
|
|
| 1994
|
Bed rest in pregnancy
1994
|
|
| 1994
|
Characteristics of severe hypoglycemia in the patient with insulin-dependent diabetes
1994
|
|
| 1994
|
Data discrepancies and audit effects in the umbilical artery catheter trial
1994
|
|
| 1994
|
Diagnoses, symptoms, and attribution of symptoms among black and white inpatients admitted for coronary heart disease
1994
|
|
| 1994
|
Effect of a National Cancer Institute Clinical Alert on breast cancer practice patterns
1994
|
|
| 1994
|
Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: A decision analysis
1994
|
|
| 1993
|
Rose Questionnaire responses among black and white inpatients admitted for coronary heart disease: findings from the Birmingham-BHS Project.
1993
|
|
| 1993
|
Fetal biparietal diameter, head circumference, abdominal circumference and femur length: A comparison by race and sex
1993
|
|
| 1993
|
Promoting physical activity in low-income African-American communities: the PARR project.
1993
|
|
| 1993
|
Initial Acquisition of Mutans Streptococci by Infants: Evidence for a Discrete Window of Infectivity
1993
|
|
| 1993
|
Low-dose aspirin therapy to prevent preeclampsia
1993
|
|
| 1993
|
Maternal risk factors and their influence on fetal anthropometric measurements
1993
|
|
| 1993
|
Physical activity of public housing residents in Birmingham, Alabama
1993
|
|
| 1993
|
Radiographic Changes Associated with Tracheal Isolation of Ureaplasma Urealyticum from Neonates
1993
|
|
| 1993
|
The feasibility of long-term treatment of diabetes with continuous subcutaneous insulin infusion
1993
|
|
| 1993
|
The relationship between maternal hematocrit and pregnancy outcome: black-white differences.
1993
|
|
| 1993
|
Transmission of mutans streptococci to infants following short term application of an iodine‐NaF solution to mothers' dentition
1993
|
|
| 1992
|
Serum folate and fetal growth retardation: a matter of compliance?
1992
|
|
| 1992
|
Blood pressure, growth retardation, and preterm delivery
1992
|
|
| 1992
|
Distributed data analysis in a multicenter study: The CARDIA study
1992
|
|
| 1992
|
Effect of conventional dental restorative treatment on bacteria in saliva
1992
|
|
| 1992
|
Elevated levels of midtrimester maternal serum α-fetoprotein are associated with preterm delivery but not with fetal growth retardation
1992
|
|
| 1992
|
Factors predicting efficacy of phentolamine-papaverine intracorporeal injection for treatment of erectile dysfunction in diabetic male
1992
|
|
| 1992
|
Maternal serum folate and zinc concentrations and their relationships to pregnancy outcome
1992
|
|
| 1992
|
Relationship of intraventricular hemorrhage or death with the level of umbilical artery catheter placement: A multicenter randomized clinical trial
1992
|
|
| 1992
|
Serum folate and fetal growth retardation: A matter of compliance?
1992
|
|
| 1992
|
Symptom-limited graded treadmill exercise testing in young adults in the CARDIA study
1992
|
|
| 1992
|
The influence of previous low birth weight on birth weight, gestational age, and anthropometric measurements in the current pregnancy
1992
|
|
| 1992
|
The relationships among psychosocial profile, maternal size, and smoking in predicting fetal growth retardation
1992
|
|
| 1992
|
Usefulness of various maternal skinfold measurements for predicting newborn birth weight
1992
|
|
| 1991
|
Black-white differences in newborn anthropometric measurements.
1991
|
|
| 1991
|
Cardiovascular risk factors in young adults. The CARDIA baseline monograph.
1991
|
|
| 1991
|
Black-white differences in newborn anthropometric measurements
1991
|
|
| 1991
|
Cardiovascular risk factors in young adults. The CARDIA baseline monograph
1991
|
|
| 1991
|
Maternal serum alpha<inf>2</inf>-macroglobulin and fetal growth retardation
1991
|
|
| 1991
|
Oral leukoplakia and adolescent smokeless tobacco use
1991
|
|
| 1991
|
Risk factors and the natural history of coronary heart disease in blacks
1991
|
|
| 1991
|
The relationship between maternal hematocrit and pregnancy outcome
1991
|
|
| 1991
|
The relationship between maternal serum zinc levels during pregnancy and birthweight
1991
|
|
| 1990
|
Estimating the Mean, Variance, and Confidence Limits from Censored (Limit of Detection), Lognormally-Distributed Exposure Data
1990
|
|
| 1990
|
A positive association between maternal serum zinc concentration and birth weight
1990
|
|
| 1990
|
Alcohol intake and blood pressure in young adults: The CARDIA study
1990
|
|
| 1990
|
Cigarette smoking behavior is strongly related to educational status: The cardia study
1990
|
|
| 1990
|
Intrauterine growth retardation and preterm delivery: prenatal risk factors in an indigent population
1990
|
|
| 1990
|
Intrauterine growth retardation is not the same as small for gestational age (I: Reply)
1990
|
|
| 1990
|
Racial differences in serum cotinine levels among smokers in the Coronary Artery Risk Development in (Young) Adults Study
1990
|
|
| 1990
|
Reply
1990
|
|
| 1990
|
Smoking, maternal age, fetal growth, and gestational age at delivery
1990
|
|
| 1990
|
The effect of thiazide therapy on glucose, insulin and cholesterol metabolism and of glucose on potassium: Results of a cross-sectional study in patients from the Hypertension Detection and Follow-up Program
1990
|
|
| 1990
|
Warning symptoms, uterine contractions, and cervical examination findings in women at risk of preterm delivery
1990
|
|
| 1989
|
Efficacy of a premixed semisynthetic human insulin regimen
1989
|
|
| 1989
|
Patient preference between clear and yellow lenses for binocular indirect ophthalmoscopy
1989
|
|
| 1989
|
A Randomized, Controlled Trial of Very Early Prophylactic Ligation of the Ductus Arteriosus in Babies Who Weighed 1000 g or Less at Birth
1989
|
|
| 1989
|
Effects of very low birth weights on fetal and neonatal mortality rates in Alabama
1989
|
|
| 1989
|
Ethnic differences in blood pressure, pulse rate, and related characteristics in young adults. The CARDIA study
1989
|
|
| 1989
|
Fluorescence microscopy of DES‐induced morphologic transformation in unfixed, cultured cells
1989
|
|
| 1989
|
Intrauterine growth retardation: Standards for diagnosis
1989
|
|
| 1989
|
Portable tonometers: a clinical comparison of applanation and indentation devices.
1989
|
|
| 1989
|
Preliminary Results From The Collaborative Alabama And Scandinavian Study Of Successive Small‐For‐Gestational Age Births: Report From a Symposium In Trondheim 9th June 1988
1989
|
|
| 1989
|
Prematurity, postdates, and growth retardation: The influence of use of ultrasonography on reported gestational age
1989
|
|
| 1989
|
Sensitivity, specificity and predictive value of saliva thiocyanate among pregnant women
1989
|
|
| 1988
|
ASSOCIATION OF UREAPLASMA UREALYTICUM INFECTION OF THE LOWER RESPIRATORY TRACT WITH CHRONIC LUNG DISEASE AND DEATH IN VERY-LOW-BIRTH-WEIGHT INFANTS
1988
|
|
| 1988
|
A cost-effectiveness analysis of self-help smoking cessation methods for pregnant women
1988
|
|
| 1988
|
Cardia: study design, recruitment, and some characteristics of the examined subjects
1988
|
|
| 1988
|
Condylomata acuminata in IDDM.
1988
|
|
| 1988
|
Cost-effectiveness of prevention, intervention, and therapeutic strategies in coronary artery disease
1988
|
|
| 1988
|
Cost-effectiveness of prevention, intervention, and therapeutic strategies in coronary artery disease
1988
|
|
| 1988
|
Factors associated with discontinuation of continuous subcutaneous insulin infusion
1988
|
|
| 1988
|
Plasmid-containing strains of Streptococcus mutans cluster within family and racial cohorts: Implications for natural transmission
1988
|
|
| 1988
|
Relationships of low density lipoprotein cholesterol with age and other factors: A cross-sectional analysis of the CARDIA study
1988
|
|
| 1987
|
A study of the cost of tuberculosis contact investigation related to non-tuberculous Mycobacterial isolation in Jefferson County, Alabama
1987
|
|
| 1987
|
Comparison of hypertension prevalence and control in 5,237 rural and urban Alabama residents
1987
|
|
| 1987
|
Fetal deaths in Alabama, 1974-1983: A birth weight-specific analysis
1987
|
|
| 1987
|
Recruitment in the Coronary Artery Disease Risk Development in Young Adults (Cardia) study
1987
|
|
| 1986
|
Prediction of response to sodium intervention for blood pressure control
1986
|
|
| 1986
|
DDT contamination of a North Alabama aquatic ecosystem
1986
|
|
| 1985
|
Low birth weight, intrauterine growth retardation, and preterm delivery
1985
|
|
| 1985
|
Dietary therapy slows the return of hypertension after stopping prolonged medication
1985
|
|
| 1985
|
Neonatal mortality in infants born weighing 501 to 1000 grams. The influence of changes in birth weight distribution and birth weight-specific mortality rates on neonatal survival
1985
|
|
| 1985
|
Dietary Therapy Slows the Return of Hypertension After Stopping Prolonged Medication
1985
|
|
| 1985
|
Late results of surgical and medical therapy for patients with coronary artery disease and depressed left ventricular function
1985
|
|
| 1985
|
The Risk of Bladder Calculi in Patients With Spinal Cord Injuries
1985
|
|
| 1985
|
The effectiveness of smoking cessation methods for smokers in public health maternity clinics: A randomized trial
1985
|
|
| 1985
|
The natural history of smoking cessation among patients undergoing coronary arteriography
1985
|
|
| 1984
|
Does effective antihypertensive therapy partially "cure" hypertension?
1984
|
|
| 1984
|
Effect of dietary change on the return of hypertension after withdrawal of prolonged antihypertensive therapy (DISH)
1984
|
|
| 1984
|
Effect of dietary change on the return of hypertension after withdrawal of prolonged antihypertensive therapy (DISH). Dietary Intervention Study of Hypertension.
1984
|
|
| 1984
|
Return of hypertension after withdrawal of prolonged antihypertensive therapy, effect of weight loss, sodium reduction, and baseline factors.
1984
|
|
| 1984
|
Association of factor B with ischemic heart disease (IHD).
1984
|
|
| 1984
|
Issues in the natural history and treatment of coronary heart disease in black populations: Surgical treatment
1984
|
|
| 1984
|
The risk of renal calculi in spinal cord injury patients
1984
|
|
| 1983
|
Baseline physical examination characteristics of the hypertensive participants
1983
|
|
| 1983
|
Hypertension detection and follow-up program. Baseline medical history characteristics of the hypertensive participants.
1983
|
|
| 1983
|
An assessment of the environmental protection agency's asbestos hazard evaluation algorithm
1983
|
|
| 1983
|
Baseline medical history characteristics of the hypertensive participants
1983
|
|
| 1983
|
Baseline physical examination characteristics of the hypertensive participants
1983
|
|
| 1983
|
Quasi-experimental designs for evaluating cancer control programs in rural settings.
1983
|
|
| 1983
|
Training and certification of blood pressure observers
1983
|
|
| 1982
|
Epidemiologic study of candidates for coronary artery bypass surgery.
1982
|
|
| 1982
|
Correlates of attendance and compliance in the hypertension detection and follow-up program
1982
|
|
| 1982
|
Epidemiologic study of candidates for coronary artery bypass surgery
1982
|
|
| 1982
|
Methodological issues in using time series designs and analysis: evaluating the behavioral impact of health communication programs.
1982
|
|
| 1982
|
Three-year incidence of hypertension in thirteen U.S. communities. On behalf of the hypertension detection and follow-up program cooperative group
1982
|
|
| 1982
|
Validation of a risk function to predict mortality in a VA population with coronary artery disease
1982
|
|
| 1981
|
Urinary Glycosaminoglycan Excretion as a Biochemical Marker in Patients with Bladder Carcinoma
1981
|
|
| 1981
|
Increasing utilization of a rural cervical cancer detection program
1981
|
|
| 1980
|
A two-compartment regression model applied to compliance in a hypertension treatment program
1980
|
|
| 1980
|
Application of survival analysis techniques to evaluation of factors affecting compliance in a clinical trial of hypertension control
1980
|
|
| 1980
|
Impact of hypertension information on high blood pressure control between 1973 and 1978
1980
|
|
| 1980
|
Mortality surveillance in collaborative trials
1980
|
|
| 1976
|
SODIUM EXCRETION AND SYMPATHETIC ACTIVITY IN RELATION TO SEVERITY OF HYPERTENSIVE DISEASE
1976
|
|
| 1976
|
Some examples for teaching regression toward the mean from a sampling viewpoint
1976
|
|
| 1886
|
Injustice to Dr. barnes
1886
|
|
